Suppr超能文献

[一例对全身化疗、经导管动脉栓塞术及肝动脉灌注化疗联合治疗有效的产甲胎蛋白胃癌病例]

[A case of AFP-producing gastric cancer responding to the combination of systemic chemotherapy, transcatheter arterial embolization and hepatic infusion chemotherapy].

作者信息

Shiochi Hideki, Yamada Minoru, Kishina Manabu, Murawaki Yoshiyuki, Miura Masahiko, Azumi Takane, Yuuki Takafumi, Tanaka Shinsuke, Kono Michimori, Yoshimura Teiji, Yoshida Manabu, Shabana Masanobu

机构信息

Dept. of Gastroenterology, Matsue City Hospital.

出版信息

Gan To Kagaku Ryoho. 2009 May;36(5):843-6.

Abstract

We report a case of a 64-year-old male with a-fetoprotein(AFP)-producing gastric cancer accompanied by large liver metastases and multiple lymph node metastases. The patient's serum AFP level was 42,307 ng/mL and a biopsy specimen showed AFP-positive tumor cells immunohistochemically. Systemic chemotherapy by tegafur gimeracil oteracil potassium(S-1)and local therapy for the hepatic metastases consisting of transcatheter arterial embolization (TAE)and infusion of epirubicin(EPI)to the hepatic arteries decreased the serum AFP level and reduced the gastric cancer and metastases. Due to the increase of AFP and lymph node metastases, we had to successively change the regimen to paclitaxel(PTX), a combination of cisplatin(CDDP)/irinotecan(CPT-11)and S-1. Continuous systemic chemotherapy in combination with various drugs for gastric cancer treatment followed by TAE and hepatic infusion chemotherapy for hepatic metastases proved effective. The patient survived for 3 years and 2 months.

摘要

我们报告一例64岁男性,患有产生甲胎蛋白(AFP)的胃癌,伴有肝脏大转移灶和多发淋巴结转移。患者血清AFP水平为42,307 ng/mL,活检标本经免疫组化显示AFP阳性肿瘤细胞。采用替吉奥(S-1)进行全身化疗,以及对肝转移灶采用经导管动脉栓塞术(TAE)和向肝动脉注入表柔比星(EPI)的局部治疗,降低了血清AFP水平,缩小了胃癌及转移灶。由于AFP升高和淋巴结转移,我们不得不先后将治疗方案改为紫杉醇(PTX)、顺铂(CDDP)/伊立替康(CPT-11)联合S-1。持续采用多种药物联合进行全身化疗治疗胃癌,随后对肝转移灶进行TAE和肝灌注化疗,证明是有效的。该患者存活了3年零2个月。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验